Ftse Mib
34.369,19
-0,02%
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
NASDAQ
18.509,34
0,20%
Bitcoin
65.152,15
0,46%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

EVG

Evgen Pharma (EVG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
11/06/201812:33Alliance NewsAlliance NewsEvgen STEM Interim Trial Result Show "Signs Of Anti-Tumour Activity"LSE:EVGEvgen Pharma Plc
11/06/201810:05UK RegulatoryEvgen Pharma PLC Second Price Monitoring ExtnLSE:EVGEvgen Pharma Plc
11/06/201810:00UK RegulatoryEvgen Pharma PLC Price Monitoring ExtensionLSE:EVGEvgen Pharma Plc
11/06/201808:00UK RegulatoryEvgen Pharma PLC Interim Update on STEM TrialLSE:EVGEvgen Pharma Plc
30/05/201808:01UK RegulatoryEvgen Pharma PLC Notification of Preliminary ResultsLSE:EVGEvgen Pharma Plc
14/05/201808:00RNS Non-RegulatoryEvgen Pharma PLC Upcoming Investor PresentationsLSE:EVGEvgen Pharma Plc
02/05/201812:15Alliance NewsAlliance NewsEvgen Pharma Gets European Patent For Sulforaphane Stablising MethodLSE:EVGEvgen Pharma Plc
02/05/201808:00UK RegulatoryEvgen Pharma PLC Grant of further European patentLSE:EVGEvgen Pharma Plc
24/04/201808:00UK RegulatoryEvgen Pharma PLC Presentation at World Orphan Drug Congress USALSE:EVGEvgen Pharma Plc
20/03/201814:56Alliance NewsAlliance NewsEvgen Pharma Begins Research Partnership With Imperial College LondonLSE:EVGEvgen Pharma Plc
20/03/201808:00UK RegulatoryEvgen Pharma PLC Research Collaboration with Imperial CollegeLSE:EVGEvgen Pharma Plc
05/03/201813:02Alliance NewsAlliance NewsEvgen Pharma Receives Positive Sulforaphane Results From EvaulationLSE:EVGEvgen Pharma Plc
05/03/201808:00UK RegulatoryEvgen Pharma PLC Update on Novel Sulforaphane AnaloguesLSE:EVGEvgen Pharma Plc
15/01/201814:05Alliance NewsAlliance NewsEvgen Says SFX-01 Could Improve Endocrine Therapy For Breast CancerLSE:EVGEvgen Pharma Plc
15/01/201808:00UK RegulatoryEvgen Pharma PLC Poster Presentation of SFX-01 Mechanistic DataLSE:EVGEvgen Pharma Plc
10/01/201818:56Alliance NewsAlliance NewsSeneca Partners Almost Doubles Evgen Pharma Stake To 7.4% (ALLISS)LSE:EVGEvgen Pharma Plc
10/01/201817:31UK RegulatoryEvgen Pharma PLC Notification of Major Interest in SharesLSE:EVGEvgen Pharma Plc
05/01/201813:53Alliance NewsAlliance NewsTwo Investment Funds Build Stakes In Evgen Pharma (ALLISS)LSE:EVGEvgen Pharma Plc
02/01/201818:44UK RegulatoryEvgen Pharma PLC Total Voting RightsLSE:EVGEvgen Pharma Plc
28/12/201712:49UK RegulatoryEvgen Pharma PLC Result of General MeetingLSE:EVGEvgen Pharma Plc
22/12/201711:10UK RegulatoryEvgen Pharma PLC Grant of OptionsLSE:EVGEvgen Pharma Plc
13/12/201712:59Alliance NewsAlliance NewsEvgen Pharma Collaborates With King's College London On SFX-01LSE:EVGEvgen Pharma Plc
13/12/201708:00UK RegulatoryEvgen Pharma PLC Collaboration with King's College LondonLSE:EVGEvgen Pharma Plc
11/12/201708:15RNS Non-RegulatoryEvgen Pharma PLC Hardman Res.: Funded to the end of Phase II trialsLSE:EVGEvgen Pharma Plc
08/12/201709:42Alliance NewsAlliance NewsEvgen Pharma Shares Drop On Discounted Placing, Loss Stays Flat (ALLISS)LSE:EVGEvgen Pharma Plc
08/12/201708:15UK RegulatoryEvgen Pharma PLC Placing and Notice of General MeetingLSE:EVGEvgen Pharma Plc
08/12/201708:00UK RegulatoryEvgen Pharma PLC Interim ResultsLSE:EVGEvgen Pharma Plc
04/10/201710:33Alliance NewsAlliance NewsEvgen Pharma Gets European Patent For SFX-01 ManufactureLSE:EVGEvgen Pharma Plc
04/10/201708:00UK RegulatoryEvgen Pharma PLC First European Patent GrantLSE:EVGEvgen Pharma Plc
31/08/201708:01UK RegulatoryEvgen Pharma PLC Issue of Equity and Total Voting RightsLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
FBK
Finecobank
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
BC
Brunello Cucinelli
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network